skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I think it was Susan who commented about not being able to find Cineplex's dividend history. I use dividendhistory.org when I'm looking to do research on dividend history. Its free and maybe it can help Susan and others. ( http://dividendhistory.org/payout/TSX/CGX/ )

Lastly, cryptokitties... for trading and as an alternative currency. Is this actually real life or am I living in my wife's dream where cats and kittens are revered above everything else?
http://www.bbc.com/news/technology-42237162

Thanks.

John
Read Answer Asked by john on December 07, 2017
Q: Hi,

Is there a price point at which this becomes a value investment that has all of the negative factors priced in? It has been a top pick numerous times on BNN but repeated bad news has driven it down and down. Might it stabilize after tax loss selling eases? Dividend now at 3.1% is tempting. My question is whether there is a price that you would consider this a buy or if the bad news outweighs potential value and nice dividend?
Read Answer Asked by Tim on December 07, 2017
Q: Hi team,

I am heavy in tech as usual and have to scale back every once in a while. I now have some cash to deploy in other sectors. I offset my tech with industrials, financials, consumer and utilities. I avoid resources as I find it just drains my capital. I am growth and an “active” investor.

I am looking at adding a consumer stock, either BCI or ZZZ. I read your recent report on BCI and am intrigued by the trend of aging demographics and the increasing need for glasses and contact lenses. You give it a relatively strong B+ rating and it is in your Growth portfolio. I have been watching it the past week or so. It is a very thin trader. No trades at all today and bid/ask about $1.00 apart, a wide spread for a $35 stock. Would have been wider except for my bid which did not get filled.

I used to own ZZZ and got lucky in selling before the last earnings release when it missed estimates. I have been watching that lately as well. It seems to be moving up steadily from $32 and now hovers above $33, still well off its 52 week high. On Monday, the TSX approved a NCIB for ZZZ that is normally supportive of the share price.

So, should I buy some eyeware or sleepware or a bit of both to get a good night’s sleep?

Thanks again,
dave
Read Answer Asked by Dave on December 07, 2017
Q: Hi 5i,
My income portfolio is light on consumer discretionaries. What would be a good stock or two that would compliment my current holding in that space - CGX.

Looking for a bit of growth and income growth.

Thanks!
Read Answer Asked by Wayne on December 06, 2017
Q: WFT, SJ, OSB and LNR all seem to be getting hammered today - and I have searched and I don't see any bad news about any of these. Is this due to concerns over NAFTA - or is it something else?
Read Answer Asked by Gordon on December 04, 2017
Q: Hi Peter and Team,
For this year's RRIF payment, I need to sell approximately 14K of stocks as I've been almost fully invested over the last year, in large measure due to 5i's superb recommendations. The stocks listed above are in sectors where I am overweight. I have several questions, so please deduct credits as you see fit:
(1) If I sold CGX outright, I'd obtain roughly 14K and would reduce my total number of holdings and lower my overweight consumer discretionary stocks. Even though CGX has fallen from its lofty heights, I'm still up, especially when factoring in the accumulated dividends. Also, there would be only one sell transaction. Are you OK with this plan?
(2) Are there any others in the list that could/should be an outright sell?
(3) Or, would a better plan be to reduce holdings in each stock by taking profits?
Of course, this would mean more sell transaction fees.

As always, I defer to your recommendations, and have been rewarded for doing so. Thanks in advance.









Read Answer Asked by Jerry on December 04, 2017
Q: Hi,
I'm interested in adding a cannabis pharmaceutical to my portfolio and am curious if you have any input or recommendations. I like ISOL but am having a hard time finding reports for them. I'm aware that this is a high risk speculative investment but I feel there's a promising future for CBDs in medicine and would like to start a small position. I've listed a few companies I'm interested in but am open to others.

Thanks
Read Answer Asked by Dennis on December 04, 2017
Q: Good Morning 5i
What is your view of this stock? Coming on BNN today at 11:30 or 1:40 Monday. Says it has first Hops derived Non-Cannabis cannabidiol CBD for world-wide medical market. Product not-marijuana based therefore not regulated as heavily world wide. What are your thoughts on whether this has legs? Any financials or discussions world-wide showing demand potential for such a product?
Thanks.
Read Answer Asked by Randy on December 04, 2017
Q: What is your opinion of Miniso's effect on Dollarama? I was going to start a position on the current pullback but am reconsidering now...

http://business.financialpost.com/news/retail-marketing/is-dollarama-about-to-meet-its-match-miniso-japans-2-99-store-plans-to-open-500-shops

Thanks
Read Answer Asked by John on December 01, 2017
Q: Hello
I am looking at Canadian non-cyclical segment stocks.

What are your thoughts on TPX.B and SAP?
Can you also comment on their projected growth for 2018?

I currently own some Premium Brand, Aliment Couch Tard, Coke, and Mondalez.

Am I over diversifying by adding two more names to my Non-Cyclical segment in your view?

Thank you!
Stephane







Read Answer Asked by Stephane on December 01, 2017
Q: Hello Peter and Ryan,
What do you think of Cannibix as a speculative play? Also, are you aware of companies that do breathalyzers for alcohol so that i can get an idea if the concept will take off from a market potential? Any idea why Aurora keeps going up while Cannimed is stagnant at 19-20 range when the offer is at 24? The results for Couche Tard were good. I would have expected a surge in the stock but it closed only a percentage higher. Was there anything in the news that may have tempered the stock price? Thanks very much.
Read Answer Asked by umedali on November 30, 2017
Q: Hi team,
I am not sure if this is a question or a comment. My curiousity was raised earlier today when I read a question from Kenneth on MYM. I thought I was the only one who heard of it and it was barely for me as it was only a week ago. Many years ago, I used to dabble in the penny stocks but that is usually a losing game. These days I am mainly a large cap momentum style.
Anyway, through a friend of a friend out in Vancouver (you get the picture), I heard of MYM and PUF a week ago in the cannabis space, planning to build a greenhouse in Australia. I think MYM owns 25% of PUF who is leading the construction phase of the project in a joint venture with a construction company that I think is really a company. So, I think there is a question here. Is PUF the best symbol ever for a stock and are its prospects just another puff of smoke?
Thanks again,
dave
Read Answer Asked by Dave on November 30, 2017